WAYHS CA, Von DIEMEN T. Pharmacovigilance Program impact on notifications of adverse reactions to antineoplastic drug in a university hospital. J Hosp Pharm Health Serv [Internet]. 2024 Jun. 29 [cited 2025 Oct. 24];15(2):e1118. Available from: https://jhphs.org/sbrafh/article/view/1118